SCHEMBL27664162

SCHEMBL27664162

CNC(=O)C(C)(C)c1cc(O)cc(Cl)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HCAR1 Q9BXC0 1/20 0.39
▸ GABRA1 P14867 1/20 0.36
▸ GABRB2 P47870 1/20 0.36
▸ CNR2 P34972 4/20 0.36
▸ GAA P10253 2/20 0.36
▸ POLB P06746 1/20 0.34
▸ FFAR2 O15552 1/20 0.34
▸ KDM4E B2RXH2 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ HCRTR1 O43613 1/20 0.32
▸ HCRTR2 O43614 1/20 0.32
▸ BRAF P15056 1/20 0.32
▸ CNR1 P21554 1/20 0.31
▸ AKR1C3 P42330 1/20 0.31
▸ AKR1C2 P52895 1/20 0.31
▸ ACLY P53396 1/20 0.31
▸ PDK1 Q15118 1/20 0.31
▸ PDK2 Q15119 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13271102 0.89 CNR2 (0.40) CNR2GAAPOLBFFAR2CNR1
SCHEMBL25460880 0.79 CA12 (0.40) HCAR1GABRA1GABRB2GAAMEN1
SCHEMBL13363407 0.74 FFAR2 (0.50) CNR2POLBFFAR2KDM4EMEN1
SCHEMBL16117689 0.73 GABRA1 (0.68) HCAR1GABRA1GABRB2CNR2GAA
SCHEMBL1869889 0.71 CNR2 (0.51) CNR2GAAMEN1HTTKMT2A
SCHEMBL5788966 0.71 MAPT (0.55) GAAKDM4EHTT
SCHEMBL25460811 0.71 SLC6A3 (0.40) GAAFFAR2MEN1HTTKMT2A
SCHEMBL30443832 0.70 TSHR (0.44) POLBKDM4EKMT2AHCRTR1HCRTR2
SCHEMBL1203024 0.67 CNR2 (0.42) CNR2GAAPOLBMEN1KMT2A
SCHEMBL1873646 0.67 AKR1C3 (0.56) CNR2GAAMEN1KMT2ACNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1852712-B Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE 2010-06-09 — — CN disclosed
CN-1852712-A Dual NK1/NK3 antagonists for treating schizophrenia HOFFMANN LA ROCHE (CH) 2006-10-25 — — CN disclosed
Send feedback